Skip to content

Hormonal and metabolic effects of diet and physical activity in women with polycystic ovary syndrome (PCOS)

Hormonal and metabolic effects of diet and physical activity in women with polycystic ovary syndrome (PCOS) - a lifestyle intervention study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN18400086
Enrollment
50
Registered
2018-02-05
Start date
2008-07-01
Completion date
Unknown
Last updated
2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome (PCOS) Pregnancy and Childbirth Polycystic ovary syndrome (PCOS)

Interventions

The three-month individualized intervention involved changes in lifestyle designed to achieve weight loss. The diet was high in protein with little carbohydrate (40E% carbohydrates, 30E% fat and 30E%

Sponsors

Karolinska Institutet
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. All Rotterdam criteria for the diagnosis of PCOS should be met (anovulation, hyperandrogenism, polycystic ovaries) 2. 18-40 years 3. BMI >27 4. No medication or hormone-containing contraceptives for 3 months before beginning the study 5. Willing to sign informed consent Healthy controls: Women with normal weight with PCOS

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation during preceding 12 months 2. Smoking 3. Use of hormone-containing contraceptives 4. Current disease 5. Regular medication including insulin-sentizing drugs 6. Eating disorder

Design outcomes

Primary

MeasureTime frame
Weight change is measured using the body weight at baseline and 12 weeks.

Secondary

MeasureTime frame
1. Menstrual function is evaluated using recordings of menstrual pattern and blood sampling of hormones during the intervention. The menstrual function is considered to be improved from baseline to 12 weeks when there is a shift from amenorrhea to oligomenorrhea/regular menstruation or from oligomenorrhea to regular menstruation and/or ovulation is confirmed by increased serum progesterone >17 nmol/L 2. Insulin sensitivity of the endometrium is measured using determination of gene and protein levels of molecules involved in insulin signaling at baseline and 12 weeks 3. Endometrial hormone receptor expression is measured using determination of gene and protein levels of hormone receptors at baseline and 12 weeks

Countries

Sweden

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 20, 2026